Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Monday, October 17, 2016

Endovascular stroke treatment following recent positive clinical trials

Once again I bet they did nothing to account for the neuronal cascade of death by these 5 causes in the first week.
http://search.naric.com/research/rehab/redesign_record.cfm?search=2&type=all&criteria=I242433&phrase=no&rec=242433&article_source=CIRRIE&international=1&international_language=&international_location=
  Endovaskuläre Schlaganfallbehandlung vor dem Hintergrund der aktuellen positiven klinischen Studien.  Der Nervenarzt , Volume 87(4) , Pgs. 433-448.

NARIC Accession Number: I242433.  What's this?
Author(s): G. Thomalla; J. Fiehler.
Publication Year: 2016.
Abstract: This article outlines the benefits of endovascular stroke treatment in stroke patients with occlusion of proximal intracranial arteries. Recently, five independent randomized controlled clinical trials demonstrated the efficacy and safety of this stroke treatment. The five trials, MR CLEAN, ESCAPE, EXTEND-IA, SWIFT-PRIME and REVASCAT, randomized a total of 1287 stroke patients to either standard treatment, which in the majority of patients consisted of intravenous thrombolysis within 4.5 hours of symptom onset or additional endovascular stroke treatment. In all the studies, endovascular treatment resulted in a better clinical outcome with an odds ratio for a better clinical outcome 90 days after stroke ranging between 1.7 and 3.1 and an absolute increase in the proportion of patients with functionally independent outcome between 14% and 31 %. The overwhelming benefit of endovascular treatment mainly results from mechanical thrombectomy using stent retriever devices and starting endovascular treatment within 6 hours of symptom onset in stroke patients.
Descriptor Terms: Clinical trials, Stroke.
Language: German
Geographic Location(s): Europe, Germany.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: http://link.springer.com/article/10.1007/s00115-015-0038-0.

Citation: G. Thomalla, J. Fiehler. (2016). Endovascular stroke treatment following recent positive clinical trials.  Endovaskuläre Schlaganfallbehandlung vor dem Hintergrund der aktuellen positiven klinischen Studien.  Der Nervenarzt , 87(4), Pgs. 433-448. Retrieved 10/15/2016, from REHABDATA database.

No comments:

Post a Comment